{"name":"Celgene Corporation","slug":"celgene-corporation","ticker":"","exchange":"","domain":"celgenecorporation.com","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"Pharma / Biotech","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[],"pipeline":[],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMi4AFBVV95cUxQdXpYSVNNZTRCNkt3bHBYYldTSWNnNnozTFZNNWNPdjRCUXBzb05JLVdIVnRzOUFCSklwLWFySk5IaDYzakFpcTJkSlNPaDdFZnE1RkJDbG1Rd0ZVSnZrUWRhVjBzRklDdkpBU20wbTRGeEo0WGJHb2NidEhBTk5EaGN0MTk5QWJaMGhkUVpMQldvR3dvOW1Bd29ULWFON2NfTnJFUU1wTkVRdEY4Vnc2MTBDZ29kVTNCeExhODMyTnU1Um9paGkzOUNRQ3RIaUhyMUxzaWZuNGx1VnZ2TmUySA?oc=5","date":"2025-05-14","type":"pipeline","source":"citybiz","summary":"Tonix Pharmaceuticals Appoints Joseph Hand, Esq., as General Counsel and Executive Vice President of Operations - citybiz","headline":"Tonix Pharmaceuticals Appoints Joseph Hand, Esq., as General Counsel and Executive Vice President of Operations","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMingFBVV95cUxNUS05cl9OazFfOThqTkVDZHk4ZG9wMVNwTnphOU9sM1dZaml1M040N0w2Yl9xZDdPTzV4c3c3MkZaTW9uWTFKRzhOZHlmbTRYY0M3UE9DTS1nWkM3MDBlaGtTMl9md3ZLUlZScWVBbTBTNk5lR01UQkxkbTVRSDZnSVkxV09XRkx5NUZwV1JhMnNRTGZDTVowcm9keHJlUQ?oc=5","date":"2022-08-01","type":"pipeline","source":"Pharma Voice","summary":"A glimpse inside Bristol Myers Squibb’s integration with Celgene - Pharma Voice","headline":"A glimpse inside Bristol Myers Squibb’s integration with Celgene","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiuAFBVV95cUxNTHpBVi1aYWo3RF9xTGFqSkhoWTlyTndvRm5kRGRhZjR2MmpxeUxRTnZKeTh3Y3pjWWJ0WE5wbmV6R19za01JUGRhSFdodG9idWdaZ0FPSjlUZUlqNDdQcW1VaGFxZkhwT0NGWEp3X2xNMXdzZXZmdURPTXRLVUlmTy1zd0xfM0poRkpTSE1mRnRSODVnOWVGM2JSZ2tucWpPZGE4a2Uta1FleEFaX1BLUUtYelU0eDVZ?oc=5","date":"2021-11-05","type":"patent","source":"Reuters","summary":"Mylan's win against Celgene drug-patent claims OK'd by Fed Circ. - Reuters","headline":"Mylan's win against Celgene drug-patent claims OK'd by Fed Circ.","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiowFBVV95cUxPcWgzaU56d05BZ0RFVmtGVzV5NTQzMWVxWEc5YVhHUkVYSGN0NXVCMTUtLTRMNHBUdTBxNEVYT0R1RHFUMzZlbXY0QlpmcllONTRtRTBoZWE1cG8yTkI3SWtYcmR3UnpWMzkwVjN0QWZON1JKR1VWX0VpUXdmdjBqeUlIcm90U0VpZ0FFNXA1SU1TdnczbmZlZGZ3d1czOE5BbWlJ?oc=5","date":"2021-07-02","type":"patent","source":"Generics and Biosimilars Initiative","summary":"Celgene settles Revlimid patent litigation with Natco Pharma - Generics and Biosimilars Initiative","headline":"Celgene settles Revlimid patent litigation with Natco Pharma","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMitwFBVV95cUxPLXhKQ095SE9fdlN5R3ZhZDBZcndMZjZseEZZdFZQNzVRYTgwVFR2TzR0YlIxc1VYRGtTTVlOaXhmWW83NXA2R2VXM1VTX2dWNFg5MC1tUjlPQndaQ21na1MxcHd1QXhGRnNaUmlXbEc3QUdkemhqVzROTnZDZDZqeHczSjA5LXExZFdGRWNBcm9EWjJGZkdvb1hQT003QUhDVXNCSnZtZF9lUXZaM0tlckNsdmRqLWM?oc=5","date":"2020-09-30","type":"pipeline","source":"House.gov","summary":"Rep. Pressley Grills Big Pharma CEO on Devastating Impact of Skyrocketing Drug Costs - House.gov","headline":"Rep. Pressley Grills Big Pharma CEO on Devastating Impact of Skyrocketing Drug Costs","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiugFBVV95cUxOaXlkbHY1VXA2YTZJUDNEMU51amtfWkE1NU1pOVhoNFhWRmZJUmxQV1lXZW1tUUoybHlqbkZGQTA4Z2tyN2JJLTRzUE5jUnZ3cXNJNWdqbl9yNFFVazhVTVcwWWZvN2VOUUdjMXdGRkQwaWRZeTROd3d6eC1ZMDBEV2dTeFRkeWhoWUdXRm02emNOUTE2aHN1ajNCQ2pnYnVRb19RT1plMkhFZ0FXWW9RUDNhMmRzQmcybUE?oc=5","date":"2020-04-13","type":"pipeline","source":"Mintz","summary":"Celgene v. Sun Pharma Global: Satisfying Subject Matter Jurisdiction Under § 271(e)(2) - Mintz","headline":"Celgene v. Sun Pharma Global: Satisfying Subject Matter Jurisdiction Under § 271(e)(2)","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMisAFBVV95cUxPU2xZTVV3clpDN1drS2JEaUlYQnZSN3ZkenYzcm1fN0pZTGpNTWtjdzFCUmtYWlQyR2dzYmtHZllubHZYYjBDekJFaml2VHMtZWo1eEtOcnFHRENZRnJaZlhHSC01d2Z4OVJLZHJETkF6aWJLVHZMVk9sN3E0ZFBXWnhyb1FEUG5xam43VGRVZXQ0ZGVaSVFFcDVSYjdRNEpDTG9aUEJYNDJ6WS04OTZjWg?oc=5","date":"2019-11-22","type":"pipeline","source":"European Pharmaceutical Review","summary":"Bristol-Myers Squibb completes acquisition of Celgene - European Pharmaceutical Review","headline":"Bristol-Myers Squibb completes acquisition of Celgene","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMisgFBVV95cUxQOWtmSGd6eVhxRnhWcW1rcXJhTE5rUVBTWjZORXNpUy1Fc29EMjlJV3hVakowLWl0NmRQVThtWF9tM3U0alVTUUF1SndIRTUwcF84XzBwM0dyTWdNcVFJa1c3QjR4a3Y2MzIwNXhpOXFNamZSSXl4UU5KdVJaNFoyNGVmcWk5bVJfcW9GLVRhb3JmRFFiX2ZrZUJGblZpOTBDaXIxNDdnd3JaSmZoR1drOVJR?oc=5","date":"2019-01-03","type":"deal","source":"Bloomberg.com","summary":"Bristol-Myers to Buy Celgene in $74 Billion Cancer-Drug Bet - Bloomberg.com","headline":"Bristol-Myers to Buy Celgene in $74 Billion Cancer-Drug Bet","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMijwFBVV95cUxNRXdDcFRMRjNQd2xFMlhocHhlczQtb0FhUENyZmcyMTVnUkFxalJtUTNlWXZ4ZkpMQlV1Y2JHT2hwRHp2dS1CN0VxSGxNR0ZmZXFaYVNfSmpjZkx0N0tMTXdpQU9PSmZvLURYdlpKRWhfS2FqemtvNnpHN0U5V2xfZXV4TzdDakc2aXcxalh3UQ?oc=5","date":"2018-06-26","type":"deal","source":"Pharmaceutical Technology","summary":"Skyhawk’s STAR collaboration with Celgene - Pharmaceutical Technology","headline":"Skyhawk’s STAR collaboration with Celgene","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMinwFBVV95cUxQbWRfM001QXRtX05HX0hwd3FHampsT21KanVBVVFZV1dYdXJjbS1KbnpVWHd4clE4UDkxYTc5VlRUdWMtcTBYTm5CckhPRTdIVC1uR29GRTRKeDR2aU8wdEFDUGlXbHJXVFhuY09zajdNeTFRVUwydGVndWFlR05iR2FFMURoRmdyRDdtNElma052dURCX1dPT080dldYbFE?oc=5","date":"2017-06-23","type":"pipeline","source":"BioPharma Dive","summary":"Celgene-backed CRISPR company emerges with $68M Series A - BioPharma Dive","headline":"Celgene-backed CRISPR company emerges with $68M Series A","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMijAFBVV95cUxOcU1xNW5uOFpOOEktTm40M2JjeVRxZUJ4VmZkMUM4QktZcDdocjd2ZnNkNGtSek5TOEk5VDhxYVpWOW4wNWU2WUUzMmZuWXloTHlGN3BlTGloekdSNjF1bXpvaFVWQThIakFTQk1tb0xCbkNrdmpKb3hMR3pQNzZJV2VsN0VWZ3Q5SnJkZg?oc=5","date":"2015-07-02","type":"pipeline","source":"BioSpace","summary":"Celgene Snaps Up Merck & Co.'s Giant Complex in New Jersey - BioSpace","headline":"Celgene Snaps Up Merck & Co.'s Giant Complex in New Jersey","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMihgFBVV95cUxNVFljNHNka3RlYnNxX1BkUmNWOVhSMU9QUThLazR3QWVSYjFWNlRNUEUwbTRNdFZxR2c3R0JjcXN0U19GY2FmTllYdy04bjN6dlhPRm1UQmtvd3NBNUpoeFRGb1Npa0pQWkZVaDYtek1KeTAwZDBacmlSalAyeXlqTW1SREFrZw?oc=5","date":"2011-09-30","type":"pipeline","source":"OncLive","summary":"Pharmaceutical Company Profile: Celgene Corporation - OncLive","headline":"Pharmaceutical Company Profile: Celgene Corporation","sentiment":"neutral"}],"patents":[],"drugCount":0,"phaseCounts":{},"enrichmentLevel":2,"visitCount":1,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}